Peppermint Oil Sanofi 0.2 ml gastro-resistant soft capsules Ireland - English - HPRA (Health Products Regulatory Authority)

peppermint oil sanofi 0.2 ml gastro-resistant soft capsules

sanofi-aventis ireland limited t/a sanofi - peppermint oil - gastro-resistant capsule, soft - 0.2 millilitre(s) - other drugs for functional gastrointestinal disorders

AMARYL 2 MG TABLET 2.0mg Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amaryl 2 mg tablet 2.0mg milligram tablets

sanofi-aventis ireland limited t/a sanofi - glimepiride - tablets - 2.0mg milligram

AMARYL 4 MG TABLET 4.0mg Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amaryl 4 mg tablet 4.0mg milligram tablets

sanofi-aventis ireland limited t/a sanofi - glimepiride - tablets - 4.0mg milligram

NASACORT 55 micrograms/dose, nasal spray, suspension Ireland - English - HPRA (Health Products Regulatory Authority)

nasacort 55 micrograms/dose, nasal spray, suspension

sanofi-aventis ireland limited t/a sanofi - triamcinolone acetonide - nasal spray, suspension - 55 microgram(s)/dose - corticosteroids; triamcinolone

Opticrom Allergy Single Dose 2% w/v eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

opticrom allergy single dose 2% w/v eye drops, solution

sanofi-aventis ireland limited t/a sanofi - sodium cromoglicate - eye drops, solution - 2 percent weight/volume - other antiallergics; cromoglicic acid

Amaryl 1 mg tablet Ireland - English - HPRA (Health Products Regulatory Authority)

amaryl 1 mg tablet

sanofi-aventis ireland limited t/a sanofi - glimepiride - tablet - 1.0 milligram(s) - sulfonamides, urea derivatives; glimepiride

Amaryl 3 mg tablet Ireland - English - HPRA (Health Products Regulatory Authority)

amaryl 3 mg tablet

sanofi-aventis ireland limited t/a sanofi - glimepiride - tablet - 3 milligram(s) - sulfonamides, urea derivatives; glimepiride

Acomplia European Union - English - EMA (European Medicines Agency)

acomplia

sanofi-aventis - rimonabant - obesity - antiobesity preparations, excl. diet products - as an adjunct to diet and exercise for the treatment of obese patients (bmi 30 kg/m2), or overweight patients (bmi 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).

Insulin Human Winthrop European Union - English - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Zimulti European Union - English - EMA (European Medicines Agency)

zimulti

sanofi-aventis - rimonabant - obesity - antiobesity preparations, excl. diet products - as an adjunct to diet and exercise for the treatment of obese patients (bmi 30 kg/m2), or overweight patients (bmi 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).